Recruiting Chronic Lymphocytic Leukemia Studies in Chicago
About Chronic Lymphocytic Leukemia Clinical Trials in Chicago
Chronic lymphocytic leukemia (CLL) is a slow-growing cancer of the blood and bone marrow that affects B lymphocytes. It is the most common type of adult leukemia. Treatment options include targeted therapies, chemotherapy, and immunotherapy.
There are currently 6 chronic lymphocytic leukemia clinical trials recruiting participants in Chicago, IL. These studies are seeking a combined 2,649 participants. Research is being sponsored by BeiGene, Nurix Therapeutics, Inc., BeOne Medicines and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Chronic Lymphocytic Leukemia Clinical Trials in Chicago — FAQ
Are there chronic lymphocytic leukemia clinical trials in Chicago?
Yes, there are 6 chronic lymphocytic leukemia clinical trials currently recruiting in Chicago, IL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Chicago?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you about next steps.
Are clinical trials in Chicago free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chicago studies also compensate for your time and travel.
What chronic lymphocytic leukemia treatments are being tested?
The 6 active trials in Chicago are testing new therapies including novel drugs, biologics, and treatment approaches for chronic lymphocytic leukemia.
Data updated October 18, 2026 from ClinicalTrials.gov